{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37385286",
  "DateCompleted": {
    "Year": "2023",
    "Month": "09",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "10",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "06",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/S2666-5247(23)00115-5",
      "S2666-5247(23)00115-5"
    ],
    "Journal": {
      "ISSN": "2666-5247",
      "JournalIssue": {
        "Volume": "4",
        "Issue": "9",
        "PubDate": {
          "Year": "2023",
          "Month": "Sep"
        }
      },
      "Title": "The Lancet. Microbe",
      "ISOAbbreviation": "Lancet Microbe"
    },
    "ArticleTitle": "Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies.",
    "Pagination": {
      "StartPage": "e745",
      "EndPage": "e756",
      "MedlinePgn": "e745-e756"
    },
    "Abstract": {
      "AbstractText": [
        "In this Personal View, we discuss current knowledge on SARS-CoV-2 RNA or antigen persistence in children infected with SARS-CoV-2. Based on the evidence that the virus can persist in adults, we have done a literature review and analysed studies that looked for SARS-CoV-2 RNA or antigens in children undergoing autopsy, biopsy, or surgery for either death from COVID-19 or multisystem inflammatory syndrome, or assessments for long COVID-19 or other conditions. Our analysis suggests that in children, independent from disease severity, SARS-CoV-2 can spread systemically and persist for weeks to months. We discuss what is known about the biological effects of viral persistence for other viral infections and highlight new scenarios for clinical, pharmacological, and basic research exploration. Such an approach will improve the understanding and management of post-viral syndromes."
      ],
      "CopyrightInformation": "Copyright \u00a9 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Centro di Salute Globale, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy. Electronic address: danilo.buonsenso@policlinicogemelli.it."
          }
        ],
        "LastName": "Buonsenso",
        "ForeName": "Danilo",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy."
          }
        ],
        "LastName": "Martino",
        "ForeName": "Laura",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy."
          }
        ],
        "LastName": "Morello",
        "ForeName": "Rosa",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy."
          }
        ],
        "LastName": "Mariani",
        "ForeName": "Francesco",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bradford Royal Infirmary, West Yorkshire, UK."
          }
        ],
        "LastName": "Fearnley",
        "ForeName": "Kelly",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy."
          }
        ],
        "LastName": "Valentini",
        "ForeName": "Piero",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Lancet Microbe",
    "NlmUniqueID": "101769019",
    "ISSNLinking": "2666-5247"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "SupplMeshList": [
    "pediatric multisystem inflammatory disease, COVID-19 related"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Research Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Post-Acute COVID-19 Syndrome"
    }
  ],
  "CoiStatement": "Declaration of interests DB has received grants from Pfizer and Roche Italy to study long COVID in children. DB has participated in a peer-to-peer teaching programme on COVID-19 vaccines and long COVID in children, sponsored by Pfizer. All other authors declare no competing interests."
}